Cellevolve Bio
PrivateLast Round
Seed
Nov 18, 2021
Total Funding Raised
$6M
Company Overview
Cellevolve Bio is a biotechnology company that develops and commercializes cell therapies for neglected diseases, including pediatric and rare conditions, through an integrated clinical development and commercialization platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellevolve Bio Comparables
Compare Cellevolve Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainChild Bio, Inc. | 79% | |
| ElevateBio | 69% | |
| Kincell Bio | 66% |
Cellevolve Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2021 |
Cellevolve Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hibiscus BioVentures | Seed |
| Catalytic Impact Foundation | Seed |
| Jumpstart Nova | Seed |
| Boxcar Partners | Seed |
Cellevolve Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellevolve Bio's valuation, stock price, and market status.
Is Cellevolve Bio a public or private company?
Cellevolve Bio is a private company.
What is the current stock price of Cellevolve Bio?
Cellevolve Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Cellevolve Bio worth (valuation)?
Valuation information for Cellevolve Bio is not publicly available.
Can I buy Cellevolve Bio stock?
Cellevolve Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cellevolve Bio's last funding round?
Cellevolve Bio's most recent funding round was Seed on November 18, 2021.
Who are the main investors in Cellevolve Bio?
Key investors in Cellevolve Bio include Hibiscus BioVentures, Jumpstart Nova.
Will Cellevolve Bio IPO soon?
No public IPO plans have been announced for Cellevolve Bio.
How can I track Cellevolve Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellevolve Bio's secondary market activity and sign up for updates.